The Brain Relaxation and Cerebral Metabolism in Stroke Volume Variation-directed Fluid Therapy During Supratentorial Tumors Resection: Crystalloid Solution Versus Colloid Solution
Overview
Neurosurgery
Affiliations
Background: Compared with goal-directed crystalloid therapy, goal-directed colloid therapy during high-risk surgery may improve postoperative outcome. Whether intraoperative fluid therapy based on goal-directed protocol with different types of fluid has distinctive effects on brain relaxation and cerebral metabolism during craniotomy remains unclear.
Methods: Forty patients with supratentorial brain tumors undergoing craniotomy were randomly assigned to either a Ringer's Lactate-based goal-directed group (LR group, n=20) or a 6% hydroxyethyl starch-based goal-directed group (HES group, n=20). The goal was achieved by maintaining a target stroke volume variation (SVV<13%) by volume loading with LR or HES throughout the procedure. The primary outcome is brain relaxation scales, an indirect evaluation of ICP; secondary endpoints include cerebral metabolism variables (jugular venous oxygen saturation [SjvO(2)], arterial-jugular venous differences in oxygen [CajvO(2)], glucose [A-JvGD], lactate [A-JvLD], and cerebral extraction ratio for oxygen [CERO(2)]) and fluid volumes.
Results: There is no significant difference between the LR and HES groups on brain relaxation scales (P=0.845), or measures of cerebral oxygenation and metabolism. Intragroup comparisons showed that CERO(2) increased by 14.3% (P=0.009, LR group) and 13.2% (P=0.032, HES group), respectively, and SjvO(2) was decreased by 8.8% (P=0.016, LR group) and 8.1% (P=0.026, HES group), respectively, after tumor removal, compared with baseline. During surgery, the LR group (3070±1138 mL) received more fluid than the HES group (2041±758 mL, P=0.002).
Conclusions: In patients undergoing supratentorial tumor resection, goal-directed HES therapy was not superior to goal-directed LR therapy for brain relaxation or cerebral metabolism, although less fluid was needed to maintain the target SVV in the HES-based group than in the LR-based group.
Liu X, Zhang X, Fan Y, Wang B, Wang J, Zeng M Int J Surg. 2024; 111(1):635-643.
PMID: 39037734 PMC: 11745616. DOI: 10.1097/JS9.0000000000001969.
Meyrat R, Vivian E, Sridhar A, Gulden R, Bruce S, Martinez A Medicine (Baltimore). 2023; 102(47):e36142.
PMID: 38013300 PMC: 10681460. DOI: 10.1097/MD.0000000000036142.
Liu X, Zhang X, Fan Y, Li S, Peng Y Trials. 2022; 23(1):950.
PMID: 36401274 PMC: 9675213. DOI: 10.1186/s13063-022-06859-9.
Guo M, Shi Y, Gao J, Yu M, Liu C BMC Anesthesiol. 2022; 22(1):296.
PMID: 36114451 PMC: 9479244. DOI: 10.1186/s12871-022-01836-w.
Song L, Geng Z, Ma W, Liu Y, Wang D Transl Pediatr. 2022; 10(11):2972-2984.
PMID: 34976763 PMC: 8649593. DOI: 10.21037/tp-21-281.